Reviewed,
UniProtKB/Swiss-Prot O14514 (BAI1_HUMAN)
Last modified
July 22, 2008.
Version 77.
History...
Clusters with 100%,
90%,
50% identity |
Documents (4) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Brain-specific angiogenesis inhibitor 1 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1584 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Likely to be a potent inhibitor of angiogenesis in brain and may play a significant role as a mediator of the p53 signal in suppression of glioblastoma. May function in cell adhesion and signal transduction in the brain. |
| Subunit structure | Interacts with MAGI1, MAGI3, BAIAP2 and PHYHIP. |
| Subcellular location | Cell membrane; Multi-pass membrane protein. Note= Likely to be concentrated at cell-cell adhesion sites. |
| Tissue specificity | Specifically expressed in brain. Reduced or no expression is observed in some glioblastoma cell lines and cancer tissues. |
| Induction | By p53. |
| Domain | The TSP1 repeats inhibit in vivo angiogenesis in rat cornea induced by BFGF. |
| Sequence similarities | Belongs to the G-protein coupled receptor 2 family. LN-TM7 subfamily. Contains 1 GPS domain. Contains 5 TSP type-1 domains. |
Ontologies
Keywords | |
|---|---|
| Biological process | Cell adhesion |
| Cellular component | Cell membrane Membrane |
| Domain | Repeat Signal Transmembrane |
| Molecular function | G-protein coupled receptor Receptor Transducer |
| PTM | Glycoprotein Phosphoprotein |
Gene Ontology (GO) | |
| Biological process | axonogenesis Ref.3 Traceable author statement. Source: ProtInc cell adhesion Ref.2Traceable author statement. Source: ProtInc negative regulation of cell proliferationTraceable author statement. Source: ProtInc peripheral nervous system development Ref.3Traceable author statement. Source: ProtInc signal transduction Ref.2Traceable author statement. Source: ProtInc |
| Cellular component | integral to plasma membrane Ref.2 Traceable author statement. Source: ProtInc intercellular junction Ref.2Traceable author statement. Source: ProtInc |
| Molecular function | protein binding Ref.3 Traceable author statement. Source: ProtInc |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | ||||||
Molecule processing | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 30 | 30 | Potential | |||||||
| Chain | 31 – 1584 | 1554 | Brain-specific angiogenesis inhibitor 1 | |||||||
Regions | ||||||||||
| Topological domain | 31 – 948 | 918 | Extracellular Potential | |||||||
| Transmembrane | 949 – 969 | 21 | 1 Potential | |||||||
| Topological domain | 970 – 980 | 11 | Cytoplasmic Potential | |||||||
| Transmembrane | 981 – 1001 | 21 | 2 Potential | |||||||
| Topological domain | 1002 – 1008 | 7 | Extracellular Potential | |||||||
| Transmembrane | 1009 – 1029 | 21 | 3 Potential | |||||||
| Topological domain | 1030 – 1052 | 23 | Cytoplasmic Potential | |||||||
| Transmembrane | 1053 – 1073 | 21 | 4 Potential | |||||||
| Topological domain | 1074 – 1093 | 20 | Extracellular Potential | |||||||
| Transmembrane | 1094 – 1114 | 21 | 5 Potential | |||||||
| Topological domain | 1115 – 1136 | 22 | Cytoplasmic Potential | |||||||
| Transmembrane | 1137 – 1157 | 21 | 6 Potential | |||||||
| Topological domain | 1158 – 1166 | 9 | Extracellular Potential | |||||||
| Transmembrane | 1167 – 1187 | 21 | 7 Potential | |||||||
| Topological domain | 1188 – 1584 | 397 | Cytoplasmic Potential | |||||||
| Domain | 261 – 315 | 55 | TSP type-1 1 | |||||||
| Domain | 354 – 407 | 54 | TSP type-1 2 | |||||||
| Domain | 409 – 462 | 54 | TSP type-1 3 | |||||||
| Domain | 467 – 520 | 54 | TSP type-1 4 | |||||||
| Domain | 522 – 575 | 54 | TSP type-1 5 | |||||||
| Domain | 881 – 938 | 58 | GPS | |||||||
| Region | 1365 – 1584 | 220 | Necessary for interaction with MAGI1 | |||||||
| Region | 1581 – 1584 | 4 | Indispensable for interaction with MAGI1 | |||||||
| Motif | 231 – 233 | 3 | Cell attachment site Potential | |||||||
| Compositional bias | 1411 – 1422 | 12 | Poly-Pro | |||||||
| Compositional bias | 1425 – 1430 | 6 | Poly-Pro | |||||||
Amino acid modifications | ||||||||||
| Modified residue | 1278 | 1 | Phosphoserine By similarity | |||||||
| Modified residue | 1469 | 1 | Phosphoserine By similarity | |||||||
| Glycosylation | 64 | 1 | N-linked (GlcNAc...) Potential | |||||||
| Glycosylation | 401 | 1 | N-linked (GlcNAc...) Potential | |||||||
| Glycosylation | 607 | 1 | N-linked (GlcNAc...) Potential | |||||||
| Glycosylation | 692 | 1 | N-linked (GlcNAc...) Potential | |||||||
| Glycosylation | 844 | 1 | N-linked (GlcNAc...) Potential | |||||||
| Glycosylation | 877 | 1 | N-linked (GlcNAc...) Potential | |||||||
| Glycosylation | 881 | 1 | N-linked (GlcNAc...) Potential | |||||||
| Disulfide bond | 273 ↔ 309 | By similarity | ||||||||
| Disulfide bond | 277 ↔ 314 | By similarity | ||||||||
| Disulfide bond | 288 ↔ 299 | By similarity | ||||||||
| Disulfide bond | 366 ↔ 400 | By similarity | ||||||||
| Disulfide bond | 370 ↔ 406 | By similarity | ||||||||
| Disulfide bond | 381 ↔ 390 | By similarity | ||||||||
| Disulfide bond | 421 ↔ 456 | By similarity | ||||||||
| Disulfide bond | 425 ↔ 461 | By similarity | ||||||||
| Disulfide bond | 436 ↔ 446 | By similarity | ||||||||
| Disulfide bond | 479 ↔ 514 | By similarity | ||||||||
| Disulfide bond | 483 ↔ 519 | By similarity | ||||||||
| Disulfide bond | 494 ↔ 504 | By similarity | ||||||||
| Disulfide bond | 534 ↔ 569 | By similarity | ||||||||
| Disulfide bond | 538 ↔ 574 | By similarity | ||||||||
| Disulfide bond | 549 ↔ 559 | By similarity | ||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis." Nishimori H., Shiratsuchi T., Urano T., Kimura Y., Kiyono K., Tatsumi K., Yoshida S., Ono M., Kuwano M., Nakamura Y., Tokino T. Oncogene 15:2145-2150(1997) [PubMed: 9393972] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Fetal brain. |
| [2] | "Cloning and characterization of BAI-associated protein 1: a PDZ domain-containing protein that interacts with BAI1." Shiratsuchi T., Futamura M., Oda K., Nishimori H., Nakamura Y., Tokino T. Biochem. Biophys. Res. Commun. 247:597-604(1998) [PubMed: 9647739] [Abstract] Cited for: INTERACTION WITH MAGI1. |
| [3] | "Identification of BAIAP2 (BAI-associated protein 2), a novel human homologue of hamster IRSp53, whose SH3 domain interacts with the cytoplasmic domain of BAI1." Oda K., Shiratsuchi T., Nishimori H., Inazawa J., Yoshikawa H., Taketani Y., Nakamura Y., Tokino T. Cytogenet. Cell Genet. 84:75-82(1999) [PubMed: 10343108] [Abstract] Cited for: INTERACTION WITH BAIAP2. |
| [4] | "Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase." Wu Y., Dowbenko D., Spencer S., Laura R., Lee J., Gu Q., Lasky L.A. J. Biol. Chem. 275:21477-21485(2000) [PubMed: 10748157] [Abstract] Cited for: INTERACTION WITH MAGI3. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| AB005297 mRNA. Translation: BAA23647.1. | |
| PIR | T00026. |
| RefSeq | NP_001693.2. |
| UniGene | Hs.194654 |
3D structure databases | |
| HSSP | HSSP built from PDB template 1LSL based on UniProtKB P07996. |
| ModBase | Search... |
Protein family/group databases | |
| GPCRDB | Search... |
PTM databases | |
| PhosphoSite | O14514. |
Genome annotation databases | |
| Ensembl | ENSG00000181790. Homo sapiens. [Contig view] |
| GeneID | 575. |
| KEGG | hsa:575. |
Organism-specific databases | |
| H-InvDB | HIX0025534. |
| HGNC | HGNC:943. BAI1. |
| MIM | 602682. gene. |
| PharmGKB | PA25247. |
| GenAtlas | Search... |
| GeneCards | Search... |
Phylogenomic databases | |
| HOGENOM | O14514. |
| HOVERGEN | O14514. |
Gene expression databases | |
| ArrayExpress | O14514. |
| CleanEx | HS_BAI1. |
| GermOnline | ENSG00000181790. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR008077. GPCR_2_brain-spec_angio_inhib. IPR001879. GPCR_2_extracellular. IPR000832. GPCR_2_secretin-like. IPR000203. PKD_cys_rich. IPR000884. TSP1. IPR008085. TSP_1. [Graphical view] |
| Pfam | PF00002. 7tm_2. 1 hit. PF01825. GPS. 1 hit. PF02793. HRM. 1 hit. PF00090. TSP_1. 5 hits. [Graphical view] |
| PRINTS | PR01694. BAIPRECURSOR. PR00249. GPCRSECRETIN. PR01705. TSP1REPEAT. |
| SMART | SM00303. GPS. 1 hit. SM00008. HormR. 1 hit. SM00209. TSP1. 5 hits. [Graphical view] |
| PROSITE | PS00649. G_PROTEIN_RECEP_F2_1. False negative. PS00650. G_PROTEIN_RECEP_F2_2. False negative. PS50227. G_PROTEIN_RECEP_F2_3. 1 hit. PS50261. G_PROTEIN_RECEP_F2_4. 1 hit. PS50221. GPS. 1 hit. PS50092. TSP1. 5 hits. [Graphical view] |
| ProDom | O14514. [Graphical view] [Entries sharing at least one domain] |
| BLOCKS | Search... |
Other Resources | |
| SOURCE | Search... |
| ProtoNet | Search... |
Entry information
| Entry name | BAI1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O14514 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| 7-transmembrane G-linked receptors List of 7-transmembrane G-linked receptor entries |
| Human chromosome 8 Human chromosome 8: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


